Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 CNS 1 Breast 1

Conditions

Memory Disorders 1 Cognitive Dysfunction 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 171 Docetaxel 164 Paclitaxel 160 Trastuzumab 152 Capecitabine 130 Tamoxifen 119 Letrozole 105 Epirubicin 93 Doxorubicin 83 Anastrozole 83 exemestane 77 Fulvestrant 75 Carboplatin 64 Fluorouracil 63 Radiotherapy 61 pertuzumab 59 Gemcitabine 55 Vinorelbine 43 Goserelin 39 eribulin 36 130-nm albumin-bound paclitaxel 36 palbociclib 32 Bevacizumab 32 ribociclib 30 Zoledronic Acid 29 Lapatinib 29 Methotrexate 28 Drug Therapy 28 Chemotherapy, Adjuvant 28 Ado-Trastuzumab Emtansine 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Donepezil × Breast × Clear all

NCT02822573 2023-09-13

Remember

Wake Forest University Health Sciences

Phase 3 Completed

276 enrolled 33 charts

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡